Eledon Pharmaceuticals (ELDN) Notes Payables (2016)
Eledon Pharmaceuticals (ELDN) posted Notes Payables of $3.4 million for Q4 2016.
Eledon Pharmaceuticals (ELDN) Notes Payables (2016) Analysis & Trends
Eledon Pharmaceuticals' Notes Payables history runs 1 years deep, the most recent figure standing at $3.4 million for Q4 2016.
- Quarterly Notes Payables changed N/A year-over-year to $3.4 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $3.4 million (changed N/A YoY) and the FY2016 annual result came in at $3.4 million, changed N/A from the prior year.
- Notes Payables was $3.4 million for Q4 2016 at Eledon Pharmaceuticals.
- Across five years, Notes Payables topped out at $3.4 million in Q4 2016 and bottomed at $3.4 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 3.45 Mn |